CINA CHEST vs Zio ECG Utilization Software (ZEUS) System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Avicenna.AI
VS
by iRhythm Technologies

AI Verdict

CINA CHEST is designed for rapid radiological triage of acute, life-threatening conditions like PE and AD using CT scans. In contrast, the Zio ECG Utilization Software (ZEUS) System focuses on analyzing continuous ECG data from wearable monitors to diagnose and manage cardiac arrhythmias. While both leverage AI in cardiology, their distinct data modalities (imaging vs. ECG) and clinical applications make them suitable for different diagnostic pathways.

Choose CINA CHEST if…

Choose CINA CHEST if your emergency department or radiology practice requires immediate, AI-powered triage for life-threatening chest conditions. This tool is ideal for rapidly detecting suspected Pulmonary Embolism or Aortic Dissection on CT angiography scans, helping prioritize critical cases and streamline radiologist workflow in acute settings.

View CINA CHEST →

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if you need a comprehensive, AI-powered solution for long-term cardiac arrhythmia detection and management. This platform is best suited for monitoring patients with suspected or known arrhythmias using wearable ECG sensors, providing detailed analysis and reports over several days to inform diagnosis and treatment plans.

View Zio ECG Utilization Software (ZEUS) System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CINA CHEST Zio ECG Utilization Software (ZEUS) System
Pricing Subscription-based Unknown
Deployment CINA runs on the AVI Platform or a third-party platform, between your scanner and your PACS. Results simply appear as an additional series, with an alert when a finding is positive for one of the pathologies CINA detects. Cloud-based.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio ECG Utilization Software (ZEUS) System

Tool B (ZEUS) offers a ZioSuite web portal and a mobile application for healthcare professionals, providing enhanced accessibility and convenience for managing patient data and reports on the go. While Tool A (CINA CHEST) operates as a standalone web application with notifications, the added mobile flexibility of Tool B gives it a slight advantage in overall usability for diverse clinical workflows.

Clinical Value

CINA CHEST

Both tools are FDA-cleared and address significant clinical needs. However, Tool A (CINA CHEST) focuses on the rapid detection and triage of acute, life-threatening conditions such as Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans, which can directly impact immediate patient outcomes in emergency settings. Tool B (ZEUS) provides highly valuable continuous ECG monitoring for diagnosing and managing cardiac arrhythmias, but the conditions targeted by Tool A generally represent more immediate, critical emergencies.

Pricing & Value

Tie

Both CINA CHEST and ZEUS System operate on non-transparent pricing models, requiring direct contact for specific details. Without any publicly available information on their pricing structures, cost-effectiveness, or detailed value propositions, it is impossible to conduct a meaningful comparison or determine a winner in this dimension.

Enterprise Readiness

CINA CHEST

Tool A (CINA CHEST) offers superior deployment flexibility, supporting cloud-based, on-premise (dedicated hardware), and virtualized (VM, Docker) environments. This broad range of options caters to a wider array of hospital IT infrastructures and security requirements, making it more adaptable for enterprise-level integration. While Tool B (ZEUS) explicitly mentions HL7-based EHR integration, Tool A's diverse deployment capabilities provide a more robust foundation for enterprise adoption.

Innovation

Zio ECG Utilization Software (ZEUS) System

Tool B (ZEUS) demonstrates a higher degree of innovation by integrating AI-powered analytics with wearable biosensors (Zio monitors) for continuous, long-term cardiac monitoring and diagnosis. This holistic approach, combining data acquisition from a physical device with cloud-based deep learning for comprehensive analysis, represents a more advanced and integrated solution compared to Tool A's focus on AI-driven image analysis for triage.

Support & Docs

Zio ECG Utilization Software (ZEUS) System

Tool B (ZEUS) offers more comprehensive and transparent support resources, including Instructions for Use available in multiple languages, dedicated customer care contact information (phone and email), and explicit 24/7 support for cybersecurity events. While Tool A (CINA CHEST) provides online Instructions for Use and a general contact email, it lacks the detailed and multi-faceted support structure evident for Tool B.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CINA CHEST Zio ECG Utilization Software (ZEUS) System
Tool Name CINA CHEST Zio ECG Utilization Software (ZEUS) System
Company Avicenna.AI iRhythm Technologies
Primary Function AI-powered radiological triage and notification software for rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
Key Detections/Analysis Detection of Pulmonary Embolism (PE) on Chest CT angiography; Detection of Aortic Dissection (AD) on Chest or Thoraco-abdominal CT angiography. AI algorithm for arrhythmia detection and classification; Continuous ECG data analysis (up to 14 days).
Data Source/Input CT angiography scans Continuous ECG data from wearable Zio monitors
Target Specialties Cardiology, Emergency Medicine, Radiology Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring CINA CHEST and Zio ECG Utilization Software (ZEUS) System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

CINA CHEST is designed for the rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. The Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data to aid physicians in the diagnosis and management of cardiac arrhythmias.
CINA CHEST analyzes Chest CT angiography or Thoraco-abdominal CT angiography scans. The Zio ECG Utilization Software (ZEUS) System processes continuous ECG data collected from wearable Zio monitors.
CINA CHEST provides radiological computer-aided triage and notifications with compressed preview images for suspected positive findings, assisting in workflow prioritization for trained radiologists. The Zio ECG Utilization Software (ZEUS) System offers a ZioSuite web portal and mobile application for healthcare professionals, generates comprehensive end-of-wear reports, and supports HL7-based EHR integration.
CINA CHEST is primarily aimed at Cardiology, Emergency Medicine, and Radiology specialties. The Zio ECG Utilization Software (ZEUS) System is designed for use in Cardiology, Family Medicine, and Internal Medicine.
CINA CHEST operates on existing CT angiography scans and functions as a standalone web application. The Zio ECG Utilization Software (ZEUS) System integrates with Zio wearable biosensors, such as the Zio monitor and Zio Watch, to collect continuous ECG data.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.